BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19951265)

  • 1. Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation.
    Vondran FW; Timrott K; Tross J; Kollrich S; Schwarz A; Lehner F; Klempnauer J; Becker T; Schwinzer R
    Transpl Int; 2010 May; 23(5):514-23. PubMed ID: 19951265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation.
    Wang Z; Shi BY; Qian YY; Cai M; Wang Q
    Clin Exp Immunol; 2009 Mar; 155(3):496-503. PubMed ID: 19141125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.
    Krystufkova E; Sekerkova A; Striz I; Brabcova I; Girmanova E; Viklicky O
    Nephrol Dial Transplant; 2012 Jun; 27(6):2576-82. PubMed ID: 22167587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of basiliximab on the proportion of regulatory T cells and their subsets early after renal transplantation: a preliminary report.
    Zhao T; Yang C; Xue Y; Qiu YY; Hu L; Qiu Y; Wang X; Yang B; Rong R; Xu M; Zhu T
    Transplant Proc; 2012 Jan; 44(1):175-8. PubMed ID: 22310608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulatory T cells in kidney transplant recipients].
    Libetta C; Portalupi V; Margiotta E; Sepe V; Canevari M; Meloni F; Morosini M; Dal Canton A
    G Ital Nefrol; 2009; 26 Suppl 45():S54-7. PubMed ID: 19382095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD25 appears non essential for human peripheral T(reg) maintenance in vivo.
    de Goër de Herve MG; Gonzales E; Hendel-Chavez H; Décline JL; Mourier O; Abbed K; Jacquemin E; Taoufik Y
    PLoS One; 2010 Jul; 5(7):e11784. PubMed ID: 20689592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.
    Fourtounas C; Dousdampanis P; Sakellaraki P; Rodi M; Georgakopoulos T; Vlachojannis JG; Mouzaki A
    Am J Nephrol; 2010; 32(1):1-9. PubMed ID: 20484893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical rejection and persistent immune regulation in kidney transplant patients.
    Hendrikx TK; Klepper M; Ijzermans J; Weimar W; Baan CC
    Transpl Immunol; 2009 Jul; 21(3):129-35. PubMed ID: 19398001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin but not everolimus inhibits chemokine receptor expression on CD4+ T cell subsets circulating in the peripheral blood of renal transplant recipients.
    Hoerning A; Köhler S; Jun C; Lu J; Fu J; Tebbe B; Dolff S; Feldkamp T; Kribben A; Hoyer PF; Witzke O
    Clin Exp Immunol; 2012 May; 168(2):251-9. PubMed ID: 22471287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-finding study of anti-CD25 antibody for targeting regulatory T cells in locoregional immunotherapy of malignant effusion.
    Okawaki M; Yamaguchi Y; Okita R; Ohara M; Okada M
    Hiroshima J Med Sci; 2008 Mar; 57(1):37-46. PubMed ID: 18578365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H.
    Bloom DD; Chang Z; Fechner JH; Dar W; Polster SP; Pascual J; Turka LA; Knechtle SJ
    Am J Transplant; 2008 Apr; 8(4):793-802. PubMed ID: 18261176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
    Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V
    Front Immunol; 2021; 12():716559. PubMed ID: 34335631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody.
    Vignali D; Gürth CM; Pellegrini S; Sordi V; Sizzano F; Piemonti L; Monti P
    Transplantation; 2016 Sep; 100(9):1853-61. PubMed ID: 27306531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
    Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
    Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.
    Sewgobind VD; Kho MM; van der Laan LJ; Hendrikx TK; van Dam T; Tilanus HW; IJzermans JN; Weimar W; Baan CC
    Nephrol Dial Transplant; 2009 May; 24(5):1635-44. PubMed ID: 19176684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of induction therapy on the homeostasis and function of regulatory T cells in kidney transplant patients.
    Bouvy AP; Klepper M; Kho MM; Boer K; Betjes MG; Weimar W; Baan CC
    Nephrol Dial Transplant; 2014 Aug; 29(8):1587-97. PubMed ID: 24771499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation.
    Bluestone JA; Liu W; Yabu JM; Laszik ZG; Putnam A; Belingheri M; Gross DM; Townsend RM; Vincenti F
    Am J Transplant; 2008 Oct; 8(10):2086-96. PubMed ID: 18828769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer.
    Okita R; Yamaguchi Y; Ohara M; Hironaka K; Okawaki M; Nagamine I; Ikeda T; Emi A; Hihara J; Okada M
    Int J Oncol; 2009 Feb; 34(2):563-72. PubMed ID: 19148493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
    Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
    Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients.
    Chu ZQ; Ji Q
    Transplant Proc; 2013; 45(1):153-6. PubMed ID: 23375290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.